Heartburn drug could help COVID-19 patients

Patients with COVID-19 who took a common heartburn medication may fare better with the virus.

A study suggests that people who took Famotidine were twice as likely to survive the virus.

TOOK A COMMON HEARTBURNMEDICINE -- MAY FARE BETTERWITH THE VIRUS.THAT'S ACCORDING TO PRELIMINARYNEW RESEARCH...PUBLISHED BY THE MEDICALJOURNAL B-M-J.THE STUDY SUGGESTS COVID-19PATIENTS WHO TOOK --(FAM-OH-TA-DEAN) FAMOTIDINE-- WERE MORE THAN TWICE ASLIKELY TO SURVIVE THE INFECTIONOR AVOID INTUBATION.THE STUDY'S CO-AUTHOR CALLEDTHE FINDINGS "ENCOURAGING" --BUT SAYS THERE'S NO EVIDENCETHE DRUG PREVENTS INFECTION.VICE PRESIDENT PENCE ISRECOMMENDING NURSING HOME